US nod for Lynparza in HRD-positive advanced ovarian cancer
admin 11th May 2020 Uncategorised 0Lynparza has been cleared for use as a first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
More: US nod for Lynparza in HRD-positive advanced ovarian cancer
Source: News